Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Biochips Based In-vitro Diagnostics Market: By Application: DNA Applications, Lab-on-chip Applications, Protein Micro-array Applications, Others; By End Use: Hospitals and Clinics, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Biochips Based In-vitro Diagnostics Market Outlook

The global biochips based in-vitro diagnostics market is expected to grow at a CAGR of 15.5% during the period 2022-2027. North America, Europe and Asia are expected to be key markets.

 

Global Market Likely to be Driven by Advancements in Biochip Technology and Increasing Research in the Domain

Biochip, a collection of multiple tests on one chip, offers multiplexing capacity to the analysis, enhancing test efficiency. Prominent technologies comprising bio/tissue chips include biosensors, microarrays, and microfluidics-based systems; the most significant, however, is Lab on a Chip (LOC). This is where other technologies are merged with microfluidics, allowing parallelism, multiplexing and ability to manipulate fluidic properties to devise complete bioassay on a biosensor surface. Applications of bio/tissue chips encompass almost every form of in-vitro diagnostics (IVD), including DNA applications (gene expression, cancer diagnosis & treatment, genomics, SNP genotyping, drug discovery, agricultural biotechnology, etc.), lab on chip applications (diagnostics, drug discovery, proteomics, genomics, IVD & POC, high throughput screening, etc.), protein microarray applications (diagnostics, expression profiling, high throughput screening, proteomics, drug discovery, etc.), other array applications (cancer diagnostics, expression profiling, genomics, drug discovery, toxico-genomics, etc.). Such applications are expected to boost the global biochips based in-vitro diagnostics market. Several major players in the IVD industry are engaged in biochips manufacturing and research.

 

Increasing Research and Development Activity and Growing Number of Applications of Biochips Expected to Boost Market Growth

In terms of demand, the total investment in research and development domain is determined by the platforms that have real world practical applications. New biochip-based technologies have significant potential to challenge or replace some microplate-based methods. Increasing research in the domain and number of products are indicative of cumulative growth. Rising number of key players in the biochip industry and growing number of applications of bio/tissue chips indicate a promising market during the forecast period. Biochips such as uTAS devices for diagnosis and implantable devices such as trauma monitoring for efficient therapeutics are some real-world applications driving the in-vitro diagnostics domain.  Such applications are expected to boost the global biochips based in-vitro diagnostics market. Researchers from the Universidad Carlos III de Madrid (UC3M), the Universidad Politécnica de Madrid (UPM) and other entities designed a novel biochip that simplified the process of manufacturing in-vitro skin in the laboratory and other complex multi-layer tissues. Human skin modelled with the help of this device could be employed in medicine and cosmetic testing, which would help decrease the cost of these preclinical trials.

Biochip applications range from human diagnostics to food analysis. For example, the PapilloCheck® test system spots various types of virus that cause cervical cancer (HPV). The ParoCheck® DNA chip recognizes a distinctive range of bacteria that cause gingivitis and periodontitis. CarnoCheck® DNA chip allows the detection of up to eight animal species in food items and animal feeds. The CytoInspecTM test system recognizes contamination with mycoplasmas in biological materials at the species level and was developed for quality assurance in the biopharmaceutical industry.

 

Market Segmentation

By application, the market is segmented into:

  • DNA Applications
  • Lab-on-chip Applications
  • Protein Micro-array Applications
  • Others

By end use, the market is classified into:

  • Hospitals and Clinics
  • Research Institutions
  • Diagnostic Centres
  • Others

By region, the market is divided into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the global biochips based in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Greiner Bio One International GmbH
  • SCHOTT AG
  • Randox Laboratories Ltd.
  • PerkinElmer, Inc. 
  • HORIBA, Ltd. 
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Application
  • End Use
  • Region
Breakup by Application
  • DNA Applications
  • Lab-on-chip Applications
  • Protein Micro-array Applications
  • Others
Breakup by End Use
  • Hospitals and Clinics
  • Research Institutions
  • Diagnostic Centres
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Greiner Bio One International GmbH
  • SCHOTT AG
  • Randox Laboratories Ltd.
  • PerkinElmer, Inc. 
  • HORIBA, Ltd. 
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Industry Opportunities and Challenges  
8    Global Biochips Based In-vitro Diagnostics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Biochips Based In-vitro Diagnostics Historical Market (2017-2021) 
    8.3    Global Biochips Based In-vitro Diagnostics Market Forecast (2022-2027)
    8.4    Global Biochips Based In-vitro Diagnostics Market by Application
        8.4.1    DNA Applications
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Lab-on-chip Applications
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Protein Micro-array Applications
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Others
    8.5    Global Biochips Based In-vitro Diagnostics Market by End Use
        8.5.1    Hospitals and Clinics
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Research Institutions
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Diagnostic Centres
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Others
    8.6    Global Biochips Based In-vitro Diagnostics Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Greiner Bio One International GmbH
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    SCHOTT AG
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Randox Laboratories Ltd.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    PerkinElmer, Inc. 
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    HORIBA, Ltd. 
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Biochips Based In-vitro Diagnostics Market: Key Industry Highlights, 2017 and 2027
2.    Global Biochips Based In-vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2017-2021
3.    Global Biochips Based In-vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2022-2027
4.    Global Biochips Based In-vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2021
5.    Global Biochips Based In-vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2022-2027
6.    Global Biochips Based In-vitro Diagnostics Historical Market: Breakup by Region (USD Million), 2017-2021
7.    Global Biochips Based In-vitro Diagnostics Market Forecast: Breakup by Region (USD Million), 2022-2027
8.    North America Biochips Based In-vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
9.    North America Biochips Based In-vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Europe Biochips Based In-vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Europe Biochips Based In-vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific Biochips Based In-vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Asia Pacific Biochips Based In-vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Latin America Biochips Based In-vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Latin America Biochips Based In-vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Middle East and Africa Biochips Based In-vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Middle East and Africa Biochips Based In-vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Global Biochips Based In-vitro Diagnostics Market Structure

Key Questions Answered in the Report

The global biochips based In-vitro diagnostics market is projected to grow at a CAGR of 15.5% between 2022 and 2027.

The major drivers of the market include the increasing research and development activity, rising number of key players in the biochip industry, rise in geriatric population, increasing adoption of next-generation sequencing, and increasing demand for cancer diagnostics and treatment.

Advancements in biochip technology and growing number of applications of biochips are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant applications of the market include DNA applications, lab-on-chip applications, and protein micro-array applications, among others.

The end-uses of the market are hospitals and clinics, research institutions, and diagnostic centres, among others.

The major players in the industry include Greiner Bio One International GmbH, SCHOTT AG, Randox Laboratories Ltd., PerkinElmer, Inc., and HORIBA, Ltd., among others.

Analyst Review

The global biochips based in-vitro diagnostics market has been driven by the growing number of applications of biochips in the historical period. Aided by the rising number of key players in the biochip industry and advancements in biochip technology, the market is expected to grow at a CAGR of 15.5% in the forecast period of 2022-2027.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The significant applications of the market are DNA applications, lab-on-chip applications, and protein micro-array applications, among others. The end-uses of the market are hospitals and clinics, research institutions, and diagnostic centres, among others. The major regional markets for biochips based in-vitro diagnostics are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the industry are Greiner Bio One International GmbH, SCHOTT AG, Randox Laboratories Ltd., PerkinElmer, Inc., and HORIBA, Ltd., among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER